Sanofi (LON:0A2V)

Market Cap	82.91B -20.5%
Revenue (ttm)	40.75B +5.5%
Net Income	6.82B +40.5%
EPS	5.58 +44.2%
Shares Out	n/a
PE Ratio	12.16
Forward PE	9.46
Dividend	1.20 (2.57%)
Ex-Dividend Date	May 9, 2025

Volume	475,614
Average Volume	74,065
Open	46.20
Previous Close	46.23
Day's Range	45.60 - 47.22
52-Week Range	44.39 - 60.08
Beta	0.40
RSI	44.57
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A2V

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR